No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NTBL Notable Labs
- 1.040
- -0.040-3.70%
Close May 16 16:00 ET
- 1.050
- +0.010+0.96%
Post 16:36 ET
9.38MMarket Cap-1071P/E (TTM)
1.110High1.000Low74.74KVolume1.060Open1.080Pre Close78.00KTurnover75.11%Turnover RatioLossP/E (Static)9.02MShares11.20052wk High0.81P/B103.48KFloat Cap0.83352wk Low--Dividend TTM99.50KShs Float595.826Historical High--Div YieldTTM10.18%Amplitude0.833Historical Low1.043Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Notable Labs Price Target Cut to $5.00/Share From $7.00 by Chardan Capital
Notable Labs Price Target Cut to $5.00/Share From $7.00 by Chardan Capital
Chardan Capital: Maintaining its rating at Notable Labs (NTBL.US), adjusted from buy to buy rating, and adjusted target price from $7.00 to $5.00.
Chardan Capital: Maintaining its rating at Notable Labs (NTBL.US), adjusted from buy to buy rating, and adjusted target price from $7.00 to $5.00.
Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5
Chardan Capital analyst Keay Nakae maintains Notable Labs (NASDAQ:NTBL) with a Buy and lowers the price target from $7 to $5.
Buy Rating Affirmed for Notable Labs Amid Promising Drug Program and Robust PPMP Platform
Notable Labs | 10-Q: Quarterly report
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg